Joeri Kint

584 total citations
10 papers, 377 citations indexed

About

Joeri Kint is a scholar working on Infectious Diseases, Animal Science and Zoology and Immunology. According to data from OpenAlex, Joeri Kint has authored 10 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Animal Science and Zoology and 3 papers in Immunology. Recurrent topics in Joeri Kint's work include SARS-CoV-2 and COVID-19 Research (7 papers), Animal Virus Infections Studies (7 papers) and Viral gastroenteritis research and epidemiology (4 papers). Joeri Kint is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Animal Virus Infections Studies (7 papers) and Viral gastroenteritis research and epidemiology (4 papers). Joeri Kint collaborates with scholars based in Netherlands, United Kingdom and Australia. Joeri Kint's co-authors include Maria Forlenza, Helena J. Maier, J.T.M. Koumans, Geert F. Wiegertjes, Paul Britton, Martijn A. Langereis, Marcela M. Fernandez-Gutierrez, Ronald Dijkman, Tomas Bergström and Eveline Kindler and has published in prestigious journals such as Journal of Virology, PLoS Pathogens and Biotechnology and Bioengineering.

In The Last Decade

Joeri Kint

10 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joeri Kint Netherlands 8 285 214 89 57 52 10 377
Felicia P. Tay Singapore 11 337 1.2× 258 1.2× 62 0.7× 116 2.0× 30 0.6× 12 462
Martina Bécares Spain 9 331 1.2× 213 1.0× 101 1.1× 129 2.3× 41 0.8× 13 526
Shangen Xu China 11 326 1.1× 307 1.4× 80 0.9× 59 1.0× 28 0.5× 18 466
Michael J. Wheadon United States 5 238 0.8× 70 0.3× 93 1.0× 151 2.6× 62 1.2× 6 427
Lili Qin China 5 284 1.0× 102 0.5× 39 0.4× 97 1.7× 72 1.4× 7 364
Tasnim Suliman Germany 5 337 1.2× 160 0.7× 62 0.7× 53 0.9× 35 0.7× 8 395
Amber W. McCall United States 6 221 0.8× 169 0.8× 176 2.0× 54 0.9× 222 4.3× 8 449
Kang An China 8 140 0.5× 150 0.7× 43 0.5× 70 1.2× 59 1.1× 17 304
Keisuke Nakagawa Japan 5 300 1.1× 106 0.5× 57 0.6× 134 2.4× 35 0.7× 9 419
Matthew Hackbart United States 7 418 1.5× 112 0.5× 124 1.4× 161 2.8× 32 0.6× 9 589

Countries citing papers authored by Joeri Kint

Since Specialization
Citations

This map shows the geographic impact of Joeri Kint's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joeri Kint with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joeri Kint more than expected).

Fields of papers citing papers by Joeri Kint

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joeri Kint. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joeri Kint. The network helps show where Joeri Kint may publish in the future.

Co-authorship network of co-authors of Joeri Kint

This figure shows the co-authorship network connecting the top 25 collaborators of Joeri Kint. A scholar is included among the top collaborators of Joeri Kint based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joeri Kint. Joeri Kint is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Triccas, James A., Joeri Kint, & Florian Μ. Wurm. (2022). Affordable SARS-CoV-2 protein vaccines for the pandemic endgame. npj Vaccines. 7(1). 89–89. 3 indexed citations
2.
McMillan, Christopher L. D., Armira Azuar, Naphak Modhiran, et al.. (2022). Dermal Delivery of a SARS-CoV-2 Subunit Vaccine Induces Immunogenicity against Variants of Concern. Vaccines. 10(4). 578–578. 10 indexed citations
3.
Counoupas, Claudio, Paco Pino, Alberto Ospina Stella, et al.. (2022). High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens. Microbiology Spectrum. 10(1). e0169521–e0169521. 14 indexed citations
4.
Pino, Paco, Joeri Kint, Divor Kiseljak, et al.. (2020). Trimeric SARS-CoV-2 Spike Proteins Produced from CHO Cells in Bioreactors Are High-Quality Antigens. Processes. 8(12). 1539–1539. 11 indexed citations
5.
Kint, Joeri, Martijn A. Langereis, Helena J. Maier, et al.. (2016). Infectious Bronchitis Coronavirus Limits Interferon Production by Inducing a Host Shutoff That Requires Accessory Protein 5b. Journal of Virology. 90(16). 7519–7528. 64 indexed citations
6.
Kint, Joeri, et al.. (2015). Quantification of Infectious Bronchitis Coronavirus by Titration In Vitro and In Ovo. Methods in molecular biology. 1282. 89–98. 10 indexed citations
7.
Kint, Joeri, Jasmin S. Kutter, Helena J. Maier, et al.. (2015). Infectious Bronchitis Coronavirus Inhibits STAT1 Signaling and Requires Accessory Proteins for Resistance to Type I Interferon Activity. Journal of Virology. 89(23). 12047–12057. 41 indexed citations
8.
Dijkman, Ronald, Tomas Bergström, Nina Kann, et al.. (2014). Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus. PLoS Pathogens. 10(5). e1004166–e1004166. 133 indexed citations
9.
Kint, Joeri, Marcela M. Fernandez-Gutierrez, Helena J. Maier, et al.. (2014). Activation of the Chicken Type I Interferon Response by Infectious Bronchitis Coronavirus. Journal of Virology. 89(2). 1156–1167. 84 indexed citations
10.
Streefland, Mathieu, Bas van de Waterbeemd, Joeri Kint, et al.. (2008). Evaluation of a critical process parameter: Oxygen limitation during cultivation has a fully reversible effect on gene expression of Bordetella pertussis. Biotechnology and Bioengineering. 102(1). 161–167. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026